{"entity":{"type":"insider","cik":"0001631338","url":"/insider/0001631338","json_url":"/insider/0001631338.json","name":"THEUER CHARLES","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":55,"n_filings":41,"first":"2015-08-18","last":"2023-04-28","span_basis":"filed_date"},"name_variants":[{"name":"THEUER CHARLES","source":"filing","n_filings":41,"first_seen":"2015-08-18","last_seen":"2023-04-28"}],"transactions":[{"id":7968938,"accession":"0001209191-23-025930","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-025930","line_url":"/filing/0001209191-23-025930#line-2","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47000.0,"shares_display":"47,000","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":35250.0,"total_display":"35,250.00","total_whole":"35,250","shares_owned_after":399417.0,"shares_owned_after_display":"399,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-27","filed_date":"2023-04-28","scope":"insider"},{"id":7968936,"accession":"0001209191-23-025930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-025930","line_url":"/filing/0001209191-23-025930#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3999.0,"shares_display":"3,999","price_per_share":0.66,"price_display":"0.66","price_state":"stated","total_value":2639.34,"total_display":"2,639.34","total_whole":"2,639","shares_owned_after":352417.0,"shares_owned_after_display":"352,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-26","filed_date":"2023-04-28","scope":"insider"},{"id":8627893,"accession":"0001209191-23-014434","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-014434","line_url":"/filing/0001209191-23-014434#line-2","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4800.0,"shares_display":"4,800","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":7296.0,"total_display":"7,296.00","total_whole":"7,296","shares_owned_after":344918.0,"shares_owned_after_display":"344,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":8627889,"accession":"0001209191-23-014434","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-014434","line_url":"/filing/0001209191-23-014434#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":304.0,"total_display":"304.00","total_whole":"304","shares_owned_after":340118.0,"shares_owned_after_display":"340,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-02","scope":"insider"},{"id":7948786,"accession":"0001209191-23-003934","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-003934","line_url":"/filing/0001209191-23-003934#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6800.0,"shares_display":"6,800","price_per_share":1.62,"price_display":"1.62","price_state":"stated","total_value":11016.0,"total_display":"11,016.00","total_whole":"11,016","shares_owned_after":339918.0,"shares_owned_after_display":"339,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-19","scope":"insider"},{"id":6735565,"accession":"0001209191-22-061329","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-061329","line_url":"/filing/0001209191-22-061329#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23000.0,"shares_display":"23,000","price_per_share":1.2937,"price_display":"1.29","price_state":"stated","total_value":29755.1,"total_display":"29,755.10","total_whole":"29,755","shares_owned_after":333118.0,"shares_owned_after_display":"333,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-15","scope":"insider"},{"id":6306503,"accession":"0001209191-22-058302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-058302","line_url":"/filing/0001209191-22-058302#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13900.0,"shares_display":"13,900","price_per_share":1.41,"price_display":"1.41","price_state":"stated","total_value":19599.0,"total_display":"19,599.00","total_whole":"19,599","shares_owned_after":310118.0,"shares_owned_after_display":"310,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-11-22","scope":"insider"},{"id":6331400,"accession":"0001209191-22-055687","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-055687","line_url":"/filing/0001209191-22-055687#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9200.0,"shares_display":"9,200","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":13984.0,"total_display":"13,984.00","total_whole":"13,984","shares_owned_after":296218.0,"shares_owned_after_display":"296,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-11-04","scope":"insider"},{"id":6374754,"accession":"0001209191-22-055435","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-055435","line_url":"/filing/0001209191-22-055435#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":1.59,"price_display":"1.59","price_state":"stated","total_value":9540.0,"total_display":"9,540.00","total_whole":"9,540","shares_owned_after":287018.0,"shares_owned_after_display":"287,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-03","scope":"insider"},{"id":6517979,"accession":"0001209191-22-053202","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-053202","line_url":"/filing/0001209191-22-053202#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.77,"price_display":"1.77","price_state":"stated","total_value":8850.0,"total_display":"8,850.00","total_whole":"8,850","shares_owned_after":277518.0,"shares_owned_after_display":"277,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-07","filed_date":"2022-10-11","scope":"insider"},{"id":6700336,"accession":"0001209191-22-052605","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-052605","line_url":"/filing/0001209191-22-052605#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.67,"price_display":"1.67","price_state":"stated","total_value":8350.0,"total_display":"8,350.00","total_whole":"8,350","shares_owned_after":272518.0,"shares_owned_after_display":"272,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":6729904,"accession":"0001209191-22-051200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-051200","line_url":"/filing/0001209191-22-051200#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.76,"price_display":"1.76","price_state":"stated","total_value":8800.0,"total_display":"8,800.00","total_whole":"8,800","shares_owned_after":267518.0,"shares_owned_after_display":"267,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-22","filed_date":"2022-09-26","scope":"insider"},{"id":6105961,"accession":"0001209191-22-043061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043061","line_url":"/filing/0001209191-22-043061#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":8325.0,"total_display":"8,325.00","total_whole":"8,325","shares_owned_after":262518.0,"shares_owned_after_display":"262,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2022-07-25","scope":"insider"},{"id":6398253,"accession":"0001209191-22-042093","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-042093","line_url":"/filing/0001209191-22-042093#line-2","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.84,"price_display":"1.84","price_state":"stated","total_value":5520.0,"total_display":"5,520.00","total_whole":"5,520","shares_owned_after":258018.0,"shares_owned_after_display":"258,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-13","filed_date":"2022-07-14","scope":"insider"},{"id":6398249,"accession":"0001209191-22-042093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-042093","line_url":"/filing/0001209191-22-042093#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.87,"price_display":"1.87","price_state":"stated","total_value":5610.0,"total_display":"5,610.00","total_whole":"5,610","shares_owned_after":255018.0,"shares_owned_after_display":"255,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-12","filed_date":"2022-07-14","scope":"insider"},{"id":6275782,"accession":"0001209191-22-028188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-028188","line_url":"/filing/0001209191-22-028188#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":18500.0,"total_display":"18,500.00","total_whole":"18,500","shares_owned_after":252018.0,"shares_owned_after_display":"252,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-09","filed_date":"2022-05-11","scope":"insider"},{"id":6251175,"accession":"0001209191-22-027975","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-027975","line_url":"/filing/0001209191-22-027975#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.97,"price_display":"1.97","price_state":"stated","total_value":4925.0,"total_display":"4,925.00","total_whole":"4,925","shares_owned_after":242018.0,"shares_owned_after_display":"242,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-06","filed_date":"2022-05-10","scope":"insider"},{"id":6847052,"accession":"0001209191-22-026562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-026562","line_url":"/filing/0001209191-22-026562#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.9709,"price_display":"1.97","price_state":"stated","total_value":9854.5,"total_display":"9,854.50","total_whole":"9,855","shares_owned_after":239518.0,"shares_owned_after_display":"239,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-29","filed_date":"2022-05-03","scope":"insider"},{"id":6098126,"accession":"0001209191-22-025471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025471","line_url":"/filing/0001209191-22-025471#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":2.3,"price_display":"2.30","price_state":"stated","total_value":10350.0,"total_display":"10,350.00","total_whole":"10,350","shares_owned_after":234518.0,"shares_owned_after_display":"234,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-21","filed_date":"2022-04-25","scope":"insider"},{"id":6751830,"accession":"0001209191-22-024070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-024070","line_url":"/filing/0001209191-22-024070#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":226518.0,"shares_owned_after_display":"226,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-08","filed_date":"2022-04-12","scope":"insider"},{"id":6727528,"accession":"0001209191-22-021876","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-021876","line_url":"/filing/0001209191-22-021876#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":10800.0,"total_display":"10,800.00","total_whole":"10,800","shares_owned_after":224518.0,"shares_owned_after_display":"224,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-30","filed_date":"2022-04-01","scope":"insider"},{"id":6607929,"accession":"0001209191-22-020678","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-020678","line_url":"/filing/0001209191-22-020678#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":2.45,"price_display":"2.45","price_state":"stated","total_value":2940.0,"total_display":"2,940.00","total_whole":"2,940","shares_owned_after":220518.0,"shares_owned_after_display":"220,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-21","filed_date":"2022-03-23","scope":"insider"},{"id":4794852,"accession":"0001209191-21-066096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-066096","line_url":"/filing/0001209191-21-066096#line-2","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":2.82,"price_display":"2.82","price_state":"stated","total_value":9870.0,"total_display":"9,870.00","total_whole":"9,870","shares_owned_after":219318.0,"shares_owned_after_display":"219,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-22","scope":"insider"},{"id":4794843,"accession":"0001209191-21-066096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-066096","line_url":"/filing/0001209191-21-066096#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":681.0,"shares_display":"681","price_per_share":2.88,"price_display":"2.88","price_state":"stated","total_value":1961.28,"total_display":"1,961.28","total_whole":"1,961","shares_owned_after":215818.0,"shares_owned_after_display":"215,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-22","scope":"insider"},{"id":4386425,"accession":"0001209191-21-063520","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-063520","line_url":"/filing/0001209191-21-063520","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":3.41375,"price_display":"3.41","price_state":"stated","total_value":13655.0,"total_display":"13,655.00","total_whole":"13,655","shares_owned_after":215137.0,"shares_owned_after_display":"215,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-05","filed_date":"2021-11-09","scope":"insider","n_lines":2},{"id":4623806,"accession":"0001209191-21-052132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-052132","line_url":"/filing/0001209191-21-052132#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.56,"price_display":"3.56","price_state":"stated","total_value":10680.0,"total_display":"10,680.00","total_whole":"10,680","shares_owned_after":207732.0,"shares_owned_after_display":"207,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-18","scope":"insider"},{"id":4657643,"accession":"0001209191-21-005826","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-005826","line_url":"/filing/0001209191-21-005826#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":8.9792,"price_display":"8.98","price_state":"stated","total_value":98771.2,"total_display":"98,771.20","total_whole":"98,771","shares_owned_after":201232.0,"shares_owned_after_display":"201,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-27","filed_date":"2021-01-28","scope":"insider"},{"id":2146970,"accession":"0001209191-20-065423","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-065423","line_url":"/filing/0001209191-20-065423#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.98,"price_display":"9.98","price_state":"stated","total_value":9980.0,"total_display":"9,980.00","total_whole":"9,980","shares_owned_after":190232.0,"shares_owned_after_display":"190,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-29","filed_date":"2020-12-30","scope":"insider"},{"id":2838769,"accession":"0001209191-20-055634","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-055634","line_url":"/filing/0001209191-20-055634#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.3845,"price_display":"4.38","price_state":"stated","total_value":8769.0,"total_display":"8,769.00","total_whole":"8,769","shares_owned_after":189232.0,"shares_owned_after_display":"189,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-21","filed_date":"2020-10-23","scope":"insider"},{"id":3091378,"accession":"0001209191-20-052046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-052046","line_url":"/filing/0001209191-20-052046","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.71980642,"price_display":"4.72","price_state":"stated","total_value":23599.0321,"total_display":"23,599.03","total_whole":"23,599","shares_owned_after":186775.0,"shares_owned_after_display":"186,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-23","filed_date":"2020-09-25","scope":"insider","n_lines":2},{"id":2248254,"accession":"0001209191-20-049800","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-049800","line_url":"/filing/0001209191-20-049800","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.575,"price_display":"2.58","price_state":"stated","total_value":25750.0,"total_display":"25,750.00","total_whole":"25,750","shares_owned_after":176882.0,"shares_owned_after_display":"176,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-04","filed_date":"2020-09-09","scope":"insider","n_lines":2},{"id":2077365,"accession":"0001209191-20-048180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-048180","line_url":"/filing/0001209191-20-048180#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5325.0,"shares_display":"5,325","price_per_share":1.56,"price_display":"1.56","price_state":"stated","total_value":8307.0,"total_display":"8,307.00","total_whole":"8,307","shares_owned_after":171882.0,"shares_owned_after_display":"171,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-21","filed_date":"2020-08-25","scope":"insider"},{"id":2343752,"accession":"0001209191-20-048026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-048026","line_url":"/filing/0001209191-20-048026#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.58,"price_display":"1.58","price_state":"stated","total_value":47400.0,"total_display":"47,400.00","total_whole":"47,400","shares_owned_after":166557.0,"shares_owned_after_display":"166,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-20","filed_date":"2020-08-24","scope":"insider"},{"id":2443392,"accession":"0001209191-20-047364","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047364","line_url":"/filing/0001209191-20-047364#line-2","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44743.0,"shares_display":"44,743","price_per_share":1.6282,"price_display":"1.63","price_state":"stated","total_value":72850.5526,"total_display":"72,850.55","total_whole":"72,851","shares_owned_after":136557.0,"shares_owned_after_display":"136,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-18","scope":"insider"},{"id":2443387,"accession":"0001209191-20-047364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047364","line_url":"/filing/0001209191-20-047364#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":1.7015,"price_display":"1.70","price_state":"stated","total_value":170.15,"total_display":"170.15","total_whole":"170","shares_owned_after":91814.0,"shares_owned_after_display":"91,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2020-08-18","scope":"insider"},{"id":2587252,"accession":"0001209191-20-046866","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-046866","line_url":"/filing/0001209191-20-046866#line-3","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":8250.0,"total_display":"8,250.00","total_whole":"8,250","shares_owned_after":91714.0,"shares_owned_after_display":"91,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-13","filed_date":"2020-08-14","scope":"insider"},{"id":2587248,"accession":"0001209191-20-046866","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-046866","line_url":"/filing/0001209191-20-046866","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":26250.0,"total_display":"26,250.00","total_whole":"26,250","shares_owned_after":86714.0,"shares_owned_after_display":"86,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-12","filed_date":"2020-08-14","scope":"insider","n_lines":2},{"id":2076817,"accession":"0001209191-20-038961","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-038961","line_url":"/filing/0001209191-20-038961#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9895.0,"shares_display":"9,895","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":18800.5,"total_display":"18,800.50","total_whole":"18,801","shares_owned_after":71714.0,"shares_owned_after_display":"71,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-24","filed_date":"2020-06-25","scope":"insider"},{"id":2369726,"accession":"0001209191-20-032058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-032058","line_url":"/filing/0001209191-20-032058","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10592.0,"shares_display":"10,592","price_per_share":1.899441087613293,"price_display":"1.90","price_state":"stated","total_value":20118.88,"total_display":"20,118.88","total_whole":"20,119","shares_owned_after":61227.0,"shares_owned_after_display":"61,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-22","filed_date":"2020-05-26","scope":"insider","n_lines":2},{"id":2435046,"accession":"0001209191-20-019015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-019015","line_url":"/filing/0001209191-20-019015#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4100.0,"shares_display":"4,100","price_per_share":1.1279,"price_display":"1.13","price_state":"stated","total_value":4624.39,"total_display":"4,624.39","total_whole":"4,624","shares_owned_after":50877.0,"shares_owned_after_display":"50,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-13","filed_date":"2020-03-13","scope":"insider"},{"id":3165651,"accession":"0001209191-20-018516","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-018516","line_url":"/filing/0001209191-20-018516","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.18025,"price_display":"1.18","price_state":"stated","total_value":11802.5,"total_display":"11,802.50","total_whole":"11,803","shares_owned_after":41777.0,"shares_owned_after_display":"41,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-12","filed_date":"2020-03-12","scope":"insider","n_lines":2},{"id":3165647,"accession":"0001209191-20-018516","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-018516","line_url":"/filing/0001209191-20-018516","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.68365,"price_display":"1.68","price_state":"stated","total_value":16836.5,"total_display":"16,836.50","total_whole":"16,837","shares_owned_after":31777.0,"shares_owned_after_display":"31,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-11","filed_date":"2020-03-12","scope":"insider","n_lines":2},{"id":2245478,"accession":"0001209191-20-017824","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-017824","line_url":"/filing/0001209191-20-017824#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":"0001631338","owner_name":"THEUER CHARLES","owner_display_name":"THEUER CHARLES","owner_url":"/insider/0001631338","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.8691,"price_display":"1.87","price_state":"stated","total_value":18691.0,"total_display":"18,691.00","total_whole":"18,691","shares_owned_after":26777.0,"shares_owned_after_display":"26,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-10","filed_date":"2020-03-10","scope":"insider"}],"collapsed":true,"next_cursor":"2020-03-10|2245478","ledger_fault":false,"count":{"value":55,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":52,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":55},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001394319","name":"Tracon Pharmaceuticals, Inc.","url":"/issuer/0001394319","role":"Director, Officer (President and CEO)","n_filings":41,"first_seen":"2015-08-18","last_seen":"2023-04-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001631338","retrieved_at":"2026-08-25T15:03:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}